Envisioning the Future of Health Care
Health care and investment industry leaders delved into emerging opportunities in pharma and life sciences during two recent virtual sessions presented by ACG.
Sectors
A Qualified Opinion: Kelley Powell
Kelley Powell, CEO and partner of MacLaurin Group, corresponded with MMG about how private equity firms should approach technology due diligence and more.
Answerthink Powers High Performance Life Science Firms
Many institutional investors have reservations when it comes to life science M&A deals—but Answerthink can address critical business challenges.
Hungry Like a Wolf
This Miami-based private equity firm continues to build out its precision machining platform by challenging industry paradigms.
Tackling the Tech Needs of SMBs
With two acquisitions under its belt this year and a rebrand set for summer, ECS/My IT takes on an overlooked market.
Using Tech to Drive DEI
How technology tools paired with new ways of thinking can help companies create more diverse, equitable and inclusive workplaces.
Marketing Meets Private Equity Business Development
A decade ago, putting up a basic website and issuing a press release after closing a deal was the extent of a typical shop's marketing activities—but no longer.
Can the Pandemic Darlings Sustain Their Growth?
Home improvement businesses, private-label food makers and fashion resellers have had a good run in the pandemic, but was it just a blip or a launchpad for lasting growth?
Opportunities and Limitations in Senior Lending
Beware debt covenants when investing in tech
Executive Spotlight: Julianna Carella
Meet Julianna Carella, CEO of Treatibles; a company that provides high-quality CBD products for pets and education to pet parents.